Alternative Therapy Failure Criteria for Nonsevere Pneumonia Show Promise
Recent research from Pakistan challenges the World Health Organization's (WHO) criteria for nonsevere pneumonia therapy failure in children, suggesting they are too sensitive. According to a study published in the International Journal of Tuberculosis and Lung Disease, alternative therapy failure criteria can identify children who require antibiotic changes more accurately, reducing unnecessary treatment modifications.
Key Takeaways:
- The WHO criteria for nonsevere pneumonia therapy failure are too sensitive, leading to unnecessary changes in antibiotic treatment in many children.
- An alternative therapy failure criterion, where children are labeled as failure only if their condition deteriorates on day 3, reduces therapy failure rates from 10.8% to 3.5%.
- The alternative criterion was tested in a nested study involving 876 children with nonsevere pneumonia, with a statistically significant difference in therapy failure rates (p=0.001).
- Using the alternative criterion, children should only have antibiotics changed if they show signs of deterioration on day 3, minimizing unnecessary treatment modifications.
- The study was conducted at the Columbus Children's Hospital in Islamabad, Pakistan, and published in the International Journal of Tuberculosis and Lung Disease.
- Dr. T. Hazir and colleagues conclude that the alternative criteria "work reasonably well, without causing any higher risk to children with nonsevere pneumonia."
Statistics:
- 876 children with nonsevere pneumonia were followed up until day 14 as part of the study.
- 95 (10.8%) children were labeled as therapy failure using current WHO criteria, compared to 31 (3.5%) using the alternative criterion.
- The difference in therapy failure rates was statistically significant (p=0.001).
- The alternative therapy failure criterion was tested in children aged 2-59 months.
Sources:
- Hazir, T., et al. "Can WHO therapy failure criteria for nonsevere pneumonia be improved in children aged 2-59 months? Int J Tuberc Lung Dis, 2006;10(8):924-931."
- International Union Against Tuberculosis Lung Disease (I U a T L D), 68 Boulevard Saint-Michel, 75006 Paris, France.
- Health & Medicine Week editors, 2006.